WO2003043585A3 - Improved particulate compositions for pulmonary delivery - Google Patents
Improved particulate compositions for pulmonary delivery Download PDFInfo
- Publication number
- WO2003043585A3 WO2003043585A3 PCT/US2002/037333 US0237333W WO03043585A3 WO 2003043585 A3 WO2003043585 A3 WO 2003043585A3 US 0237333 W US0237333 W US 0237333W WO 03043585 A3 WO03043585 A3 WO 03043585A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- particles
- drug
- improved particulate
- pulmonary delivery
- particulate compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000002685 pulmonary effect Effects 0.000 title abstract 2
- 239000002245 particle Substances 0.000 abstract 7
- 239000003814 drug Substances 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 3
- 239000000443 aerosol Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002465675A CA2465675C (en) | 2001-11-20 | 2002-11-20 | Improved particulate compositions for pulmonary delivery |
AU2002352836A AU2002352836B2 (en) | 2001-11-20 | 2002-11-20 | Improved particulate compositions for pulmonary delivery |
EP02789792.5A EP1455755B1 (en) | 2001-11-20 | 2002-11-20 | Improved particulate compositions for pulmonary delivery |
JP2003545266A JP4368198B2 (en) | 2001-11-20 | 2002-11-20 | Improved particulate composition for pulmonary delivery |
DK02789792.5T DK1455755T3 (en) | 2001-11-20 | 2002-11-20 | Improved particle composition for delivery in lung |
ES02789792T ES2415654T3 (en) | 2001-11-20 | 2002-11-20 | Enhanced particulate compositions for pulmonary delivery |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33170801P | 2001-11-20 | 2001-11-20 | |
US60/331,708 | 2001-11-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003043585A2 WO2003043585A2 (en) | 2003-05-30 |
WO2003043585A3 true WO2003043585A3 (en) | 2003-11-13 |
Family
ID=23295029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/037333 WO2003043585A2 (en) | 2001-11-20 | 2002-11-20 | Improved particulate compositions for pulmonary delivery |
Country Status (9)
Country | Link |
---|---|
US (2) | US7182961B2 (en) |
EP (1) | EP1455755B1 (en) |
JP (1) | JP4368198B2 (en) |
AU (1) | AU2002352836B2 (en) |
CA (1) | CA2465675C (en) |
DK (1) | DK1455755T3 (en) |
ES (1) | ES2415654T3 (en) |
PT (1) | PT1455755E (en) |
WO (1) | WO2003043585A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9061352B2 (en) | 2010-08-30 | 2015-06-23 | Pulmatrix, Inc. | Dry powder formulations and methods for treating pulmonary diseases |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040073438A (en) * | 2001-11-19 | 2004-08-19 | 벡톤 디킨슨 앤드 컴퍼니 | Pharmaceutical compositions in particulate form |
US20040014679A1 (en) * | 2002-02-20 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Inhalation powder containing the CGRP antagonist BIBN4096 and process for the preparation thereof |
CA2523475C (en) * | 2003-05-28 | 2013-02-05 | Nektar Therapeutics | Pharmaceutical formulation comprising a water-insoluble active agent |
US20050042178A1 (en) * | 2003-08-18 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder |
US20050042180A1 (en) * | 2003-08-18 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Powder formulation containing the CGRP antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2 (1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin, process for preparing and the use thereof as inhalation powder |
US20050191360A1 (en) * | 2004-02-10 | 2005-09-01 | Advanced Inhalation Research, Inc. | Particles for inhalation having rapid release properties |
CN101098678A (en) | 2004-04-23 | 2008-01-02 | 锡德克斯公司 | Dpi formulation containing sulfoalkyl ether cyclodextrin |
WO2006130943A1 (en) * | 2005-06-10 | 2006-12-14 | The Governors Of The University Of Alberta | Respirable dried powder formulation comprising drug loaded nanoparticles |
BRPI0614999A2 (en) * | 2005-08-11 | 2011-04-26 | Harvard College | method of producing a dry powder and said dry powder |
US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
ES2625260T5 (en) | 2009-03-26 | 2020-07-29 | Pulmatrix Operating Co Inc | Dry powder formulations and methods for the treatment of lung diseases |
US8758824B2 (en) | 2010-08-30 | 2014-06-24 | Pulmatrix, Inc. | Respirably dry powder comprising calcium lactate, sodium chloride and leucine |
CA2812414C (en) | 2010-09-29 | 2020-09-22 | Pulmatrix, Inc. | Monovalent metal cation dry powders for inhalation |
CA2812417C (en) | 2010-09-29 | 2019-10-22 | Pulmatrix, Inc. | Cationic dry powders |
WO2012103116A1 (en) * | 2011-01-24 | 2012-08-02 | Activbiotics Pharma, Llc | Pulmonary administration of rifalazil and analogs thereof |
CN104487075A (en) | 2012-02-29 | 2015-04-01 | 普马特里克斯公司 | Inhalable dry powders |
BR112015010601B1 (en) * | 2012-11-09 | 2022-07-19 | Civitas Therapeutics, Inc. | PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOSITION |
US8545878B1 (en) | 2012-11-09 | 2013-10-01 | Civitas Therapeutics, Inc. | Capsules containing high doses of levodopa for pulmonary use |
US10034988B2 (en) | 2012-11-28 | 2018-07-31 | Fontem Holdings I B.V. | Methods and devices for compound delivery |
CN105324106A (en) | 2013-04-01 | 2016-02-10 | 普马特里克斯营业公司 | Tiotropium dry powders |
EP3607941A1 (en) | 2013-04-30 | 2020-02-12 | Otitopic Inc. | Dry powder formulations and methods of use |
US10194693B2 (en) | 2013-09-20 | 2019-02-05 | Fontem Holdings 1 B.V. | Aerosol generating device |
CN106102748A (en) | 2014-02-20 | 2016-11-09 | 奥迪托皮克股份有限公司 | For the dry powder formulations sucked |
KR102603897B1 (en) | 2014-07-31 | 2023-11-20 | 벡추라 인코포레이티드 | Dry powder formulations for inhalation |
ES2841933T3 (en) | 2014-10-31 | 2021-07-12 | Univ Monash | Powder formulation |
MA40910A (en) | 2014-11-07 | 2017-09-12 | Civitas Therapeutics Inc | RAPAMYCIN POWDERS FOR PULMONARY ADMINISTRATION |
US10034857B2 (en) | 2015-07-02 | 2018-07-31 | Civitas Therapeutics, Inc. | Triptan powders for pulmonary delivery |
SG11201909478UA (en) | 2017-04-24 | 2019-11-28 | Cocrystal Pharma Inc | Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication |
WO2019126289A1 (en) * | 2017-12-21 | 2019-06-27 | Civitas Therapeutics, Inc. | Surfactant formulations for inhalation |
WO2020023813A1 (en) | 2018-07-27 | 2020-01-30 | Cocrystal Pharma, Inc. | Pyrrolo[2,3-b]pyridin derivatives as inhibitors of influenza virus replication |
TW202023566A (en) | 2018-09-10 | 2020-07-01 | 美商共結晶製藥公司 | Inhibitors of influenza virus replication |
EP3866778B1 (en) | 2018-10-17 | 2022-11-30 | Cocrystal Pharma, Inc. | Combinations of inhibitors of influenza virus replication |
US20220048897A1 (en) | 2018-11-26 | 2022-02-17 | Cocrystal Pharma, Inc. | Inhibitors of influenza virus replication |
WO2021188620A1 (en) | 2020-03-17 | 2021-09-23 | Cocrystal Pharma Inc. | Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication |
JP2023521116A (en) | 2020-04-10 | 2023-05-23 | コクリスタル ファーマ,インコーポレイテッド | Inhibitors of norovirus and coronavirus replication |
IL310394A (en) | 2021-08-03 | 2024-03-01 | Cocrystal Pharma Inc | Inhibitors for coronaviruses |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4895719A (en) * | 1985-05-22 | 1990-01-23 | Liposome Technology, Inc. | Method and apparatus for administering dehydrated liposomes by inhalation |
US6153211A (en) * | 1997-07-18 | 2000-11-28 | Infimed, Inc. | Biodegradable macromers for the controlled release of biologically active substances |
Family Cites Families (110)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2470396A (en) * | 1944-11-14 | 1949-05-17 | Joseph D Guerette | Spur shore |
US2533065A (en) | 1947-03-08 | 1950-12-05 | George V Taplin | Micropulverized therapeutic agents |
US2470296A (en) | 1948-04-30 | 1949-05-17 | Abbott Lab | Inhalator |
US2992645A (en) | 1958-05-06 | 1961-07-18 | Benger Lab Ltd | Disperser for powders |
US3957965A (en) | 1967-08-08 | 1976-05-18 | Fisons Limited | Sodium chromoglycate inhalation medicament |
US4173488A (en) | 1968-12-23 | 1979-11-06 | Champion International Corporation | Oil-in-water emulsions containing hydropholeic starch |
US3781230A (en) | 1968-12-23 | 1973-12-25 | Champion Int Corp | Microcapsular opacifier system |
GB1410588A (en) | 1971-08-10 | 1975-10-22 | Fisons Ltd | Composition |
US4089800A (en) | 1975-04-04 | 1978-05-16 | Ppg Industries, Inc. | Method of preparing microcapsules |
US4161516A (en) | 1975-07-25 | 1979-07-17 | Fisons Limited | Composition for treating airway disease |
US4272398A (en) | 1978-08-17 | 1981-06-09 | The United States Of America As Represented By The Secretary Of Agriculture | Microencapsulation process |
US4743545A (en) | 1984-08-09 | 1988-05-10 | Torobin Leonard B | Hollow porous microspheres containing biocatalyst |
US4352883A (en) | 1979-03-28 | 1982-10-05 | Damon Corporation | Encapsulation of biological material |
US4391909A (en) | 1979-03-28 | 1983-07-05 | Damon Corporation | Microcapsules containing viable tissue cells |
CY1492A (en) | 1981-07-08 | 1990-02-16 | Draco Ab | Powder inhalator |
US5260306A (en) | 1981-07-24 | 1993-11-09 | Fisons Plc | Inhalation pharmaceuticals |
EP0072046B1 (en) | 1981-07-24 | 1986-01-15 | FISONS plc | Inhalation drugs, methods for their production and pharmaceutical formulations containing them |
DE3141641A1 (en) | 1981-10-16 | 1983-04-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | ULTRASONIC CONTRAST AGENTS AND THEIR PRODUCTION |
US4480041A (en) | 1982-07-09 | 1984-10-30 | Collaborative Research, Inc. | Use of phosphotriester intermediates for preparation of functionalized liposomes |
US4572203A (en) | 1983-01-27 | 1986-02-25 | Feinstein Steven B | Contact agents for ultrasonic imaging |
US4718433A (en) | 1983-01-27 | 1988-01-12 | Feinstein Steven B | Contrast agents for ultrasonic imaging |
US4865789A (en) | 1983-11-14 | 1989-09-12 | Akzo Nv | Method for making porous structures |
WO1985002092A1 (en) | 1983-11-14 | 1985-05-23 | Bio-Mimetics Inc. | Bioadhesive compositions and methods of treatment therewith |
US4818542A (en) | 1983-11-14 | 1989-04-04 | The University Of Kentucky Research Foundation | Porous microspheres for drug delivery and methods for making same |
CA1215922A (en) | 1984-05-25 | 1986-12-30 | Connaught Laboratories Limited | Microencapsulation of living tissue and cells |
US4679555A (en) | 1984-08-07 | 1987-07-14 | Key Pharmaceuticals, Inc. | Method and apparatus for intrapulmonary delivery of heparin |
US5340587A (en) | 1985-05-22 | 1994-08-23 | Liposome Technology, Inc. | Liposome/bronchodilator method & System |
EP0248051A1 (en) | 1985-11-29 | 1987-12-09 | FISONS plc | Pharmaceutical composition including sodium cromoglycate |
GB8601100D0 (en) | 1986-01-17 | 1986-02-19 | Cosmas Damian Ltd | Drug delivery system |
US5160745A (en) | 1986-05-16 | 1992-11-03 | The University Of Kentucky Research Foundation | Biodegradable microspheres as a carrier for macromolecules |
US4741872A (en) | 1986-05-16 | 1988-05-03 | The University Of Kentucky Research Foundation | Preparation of biodegradable microspheres useful as carriers for macromolecules |
WO1988001165A1 (en) | 1986-08-11 | 1988-02-25 | Innovata Biomed Limited | Pharmaceutical formulations comprising microcapsules |
US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
DE3637926C1 (en) | 1986-11-05 | 1987-11-26 | Schering Ag | Ultrasonic manometry in a liquid using microbubbles |
JPS63122620A (en) | 1986-11-12 | 1988-05-26 | Sanraku Inc | Polylactic acid microsphere and production thereof |
US4963297A (en) | 1987-12-22 | 1990-10-16 | The Liposome Company, Inc. | Spontaneous vesticulation of multilamellar liposomes |
US5204113A (en) | 1987-04-09 | 1993-04-20 | Fisons Plc | Pharmaceutical compositions containing pentamidine |
US4861627A (en) | 1987-05-01 | 1989-08-29 | Massachusetts Institute Of Technology | Preparation of multiwall polymeric microcapsules |
US5690954A (en) | 1987-05-22 | 1997-11-25 | Danbiosyst Uk Limited | Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material |
US5069936A (en) | 1987-06-25 | 1991-12-03 | Yen Richard C K | Manufacturing protein microspheres |
US4857311A (en) | 1987-07-31 | 1989-08-15 | Massachusetts Institute Of Technology | Polyanhydrides with improved hydrolytic degradation properties |
GB8723846D0 (en) | 1987-10-10 | 1987-11-11 | Danbiosyst Ltd | Bioadhesive microsphere drug delivery system |
US4855144A (en) | 1987-10-23 | 1989-08-08 | Advanced Polymer Systems | Synthetic melanin aggregates |
JP2670680B2 (en) | 1988-02-24 | 1997-10-29 | 株式会社ビーエムジー | Polylactic acid microspheres containing physiologically active substance and method for producing the same |
US5064650A (en) | 1988-04-19 | 1991-11-12 | Southwest Research Institute | Controlled-release salt sensitive capsule for oral use and adhesive system |
US4917119A (en) | 1988-11-30 | 1990-04-17 | R. J. Reynolds Tobacco Company | Drug delivery article |
IT1228459B (en) | 1989-02-23 | 1991-06-19 | Phidea S R L | INHALER WITH REGULAR AND COMPLETE EMPTYING OF THE CAPSULE. |
US4976968A (en) | 1989-02-24 | 1990-12-11 | Clinical Technologies Associates, Inc. | Anhydrous delivery systems for pharmacological agents |
CA2050911C (en) | 1989-05-04 | 1997-07-15 | Thomas R. Tice | Encapsulation process and products therefrom |
US5176132A (en) | 1989-05-31 | 1993-01-05 | Fisons Plc | Medicament inhalation device and formulation |
US5174988A (en) | 1989-07-27 | 1992-12-29 | Scientific Development & Research, Inc. | Phospholipid delivery system |
IT1237118B (en) | 1989-10-27 | 1993-05-18 | Miat Spa | MULTI-DOSE INHALER FOR POWDER DRUGS. |
US5707644A (en) | 1989-11-04 | 1998-01-13 | Danbiosyst Uk Limited | Small particle compositions for intranasal drug delivery |
US5271961A (en) | 1989-11-06 | 1993-12-21 | Alkermes Controlled Therapeutics, Inc. | Method for producing protein microspheres |
US5123414A (en) | 1989-12-22 | 1992-06-23 | Unger Evan C | Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
US5580575A (en) | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
US5334381A (en) | 1989-12-22 | 1994-08-02 | Unger Evan C | Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
US5352435A (en) | 1989-12-22 | 1994-10-04 | Unger Evan C | Ionophore containing liposomes for ultrasound imaging |
SE9002017D0 (en) | 1990-06-06 | 1990-06-06 | Kabivitrum Ab | PROCESS FOR MANUFACTURE OF MATRICES |
US5614216A (en) | 1990-10-17 | 1997-03-25 | The Liposome Company, Inc. | Synthetic lung surfactant |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
GB9107628D0 (en) | 1991-04-10 | 1991-05-29 | Moonbrook Limited | Preparation of diagnostic agents |
SE9302777D0 (en) | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
US5874063A (en) | 1991-04-11 | 1999-02-23 | Astra Aktiebolag | Pharmaceutical formulation |
US5327883A (en) | 1991-05-20 | 1994-07-12 | Dura Pharmaceuticals, Inc. | Apparatus for aerosolizing powdered medicine and process and using |
AU659645B2 (en) | 1991-06-26 | 1995-05-25 | Inhale Therapeutic Systems | Storage of materials |
US5409688A (en) | 1991-09-17 | 1995-04-25 | Sonus Pharmaceuticals, Inc. | Gaseous ultrasound contrast media |
US5169871A (en) | 1991-12-19 | 1992-12-08 | Hoechst Celanese Corp. | Highly porous compressible polymeric powders |
CA2145418A1 (en) | 1992-09-29 | 1994-04-14 | John S. Patton | Pulmonary delivery of active fragments of parathyroid hormone |
US5698721A (en) | 1992-12-17 | 1997-12-16 | Megabios Corporation | Catonic amphiphiles |
GB9301629D0 (en) | 1993-01-27 | 1993-03-17 | Scotia Holdings Plc | Formulations containing unsaturated fatty acids |
US5994314A (en) * | 1993-04-07 | 1999-11-30 | Inhale Therapeutic Systems, Inc. | Compositions and methods for nucleic acid delivery to the lung |
US5456917A (en) | 1993-04-12 | 1995-10-10 | Cambridge Scientific, Inc. | Method for making a bioerodible material for the sustained release of a medicament and the material made from the method |
TW402506B (en) | 1993-06-24 | 2000-08-21 | Astra Ab | Therapeutic preparation for inhalation |
US5830853A (en) | 1994-06-23 | 1998-11-03 | Astra Aktiebolag | Systemic administration of a therapeutic preparation |
GB9313650D0 (en) | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
GB9313642D0 (en) | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
EP0721331B1 (en) | 1993-10-01 | 2001-12-05 | AstraZeneca AB | Process i |
ES2218543T3 (en) | 1994-03-07 | 2004-11-16 | Nektar Therapeutics | PROCEDURE AND PREPARATION FOR THE ADMINISTRATION OF INSULIN BY PULMONARY ROUTE. |
US6051256A (en) | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
JPH10500672A (en) * | 1994-05-18 | 1998-01-20 | インヘイル セラピューティック システムズ,インコーポレイティド | Methods and compositions relating to dry powder formulations of interferon |
GB9413202D0 (en) | 1994-06-30 | 1994-08-24 | Univ Bradford | Method and apparatus for the formation of particles |
US5885613A (en) | 1994-09-30 | 1999-03-23 | The University Of British Columbia | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
AR002009A1 (en) | 1994-12-22 | 1998-01-07 | Astra Ab | PHARMACEUTICAL COMPOSITION, PROCEDURE FOR THE MANUFACTURE OF A PROLIPOSOMA POWDER AS USED IN SUCH COMPOSITION, PROCEDURE FOR LAMANUFACTURE OF SUCH COMPOSITION, USE OF SUCH PHARMACEUTICAL COMPOSITION IN THE MANUFACTURE OF A DISPOSAL MEDICINAL PRODUCT. |
GB9501841D0 (en) * | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
US5612053A (en) | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
US5780014A (en) | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
US6019968A (en) | 1995-04-14 | 2000-02-01 | Inhale Therapeutic Systems, Inc. | Dispersible antibody compositions and methods for their preparation and use |
US6258341B1 (en) * | 1995-04-14 | 2001-07-10 | Inhale Therapeutic Systems, Inc. | Stable glassy state powder formulations |
US6309671B1 (en) * | 1995-04-14 | 2001-10-30 | Inhale Therapeutic Systems | Stable glassy state powder formulations |
US6136346A (en) * | 1995-04-14 | 2000-10-24 | Inhale Therapeutic Systems | Powdered pharmaceutical formulations having improved dispersibility |
US5654007A (en) | 1995-06-07 | 1997-08-05 | Inhale Therapeutic Systems | Methods and system for processing dispersible fine powders |
US5855613A (en) * | 1995-10-13 | 1999-01-05 | Islet Sheet Medical, Inc. | Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change |
US20020052310A1 (en) * | 1997-09-15 | 2002-05-02 | Massachusetts Institute Of Technology The Penn State Research Foundation | Particles for inhalation having sustained release properties |
USRE37053E1 (en) * | 1996-05-24 | 2001-02-13 | Massachusetts Institute Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
US5985309A (en) | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
US5874064A (en) * | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
US6103270A (en) * | 1996-06-07 | 2000-08-15 | Inhale Therapeutic Systems | Methods and system for processing dispersible fine powders |
WO1998029140A1 (en) * | 1996-12-31 | 1998-07-09 | Inhale Therapeutic Systems | Processes and compositions for spray drying hydrophobic drugs in organic solvent suspensions of hydrophilic excipients |
US6433040B1 (en) * | 1997-09-29 | 2002-08-13 | Inhale Therapeutic Systems, Inc. | Stabilized bioactive preparations and methods of use |
US6309623B1 (en) * | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
JP4549529B2 (en) * | 1998-01-30 | 2010-09-22 | サイオス,インコーポレーテッド | Controlled release delivery of peptides or proteins |
PL343438A1 (en) * | 1998-04-08 | 2001-08-13 | Lilly Co Eli | Pulmonary and nasal delivery of raloxifene |
US6284282B1 (en) * | 1998-04-29 | 2001-09-04 | Genentech, Inc. | Method of spray freeze drying proteins for pharmaceutical administration |
US6395300B1 (en) * | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
US20010036481A1 (en) * | 1999-08-25 | 2001-11-01 | Advanced Inhalation Research, Inc. | Modulation of release from dry powder formulations |
US6284283B1 (en) * | 1999-10-21 | 2001-09-04 | Alkermes Controlled Therapeutics, Inc. | Method of producing sub-micron particles of biologically active agents and uses thereof |
US6848197B2 (en) * | 2001-04-18 | 2005-02-01 | Advanced Inhalation Research, Inc. | Control of process humidity to produce large, porous particles |
EP1458361A4 (en) * | 2001-11-20 | 2007-04-25 | Advanced Inhalation Res Inc | Compositions for sustained action product delivery |
-
2002
- 2002-11-20 PT PT2789792T patent/PT1455755E/en unknown
- 2002-11-20 AU AU2002352836A patent/AU2002352836B2/en not_active Expired
- 2002-11-20 JP JP2003545266A patent/JP4368198B2/en not_active Expired - Lifetime
- 2002-11-20 EP EP02789792.5A patent/EP1455755B1/en not_active Expired - Lifetime
- 2002-11-20 ES ES02789792T patent/ES2415654T3/en not_active Expired - Lifetime
- 2002-11-20 WO PCT/US2002/037333 patent/WO2003043585A2/en active IP Right Grant
- 2002-11-20 CA CA002465675A patent/CA2465675C/en not_active Expired - Lifetime
- 2002-11-20 US US10/300,657 patent/US7182961B2/en not_active Expired - Lifetime
- 2002-11-20 DK DK02789792.5T patent/DK1455755T3/en active
-
2006
- 2006-12-05 US US11/633,750 patent/US7384649B2/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4895719A (en) * | 1985-05-22 | 1990-01-23 | Liposome Technology, Inc. | Method and apparatus for administering dehydrated liposomes by inhalation |
US6153211A (en) * | 1997-07-18 | 2000-11-28 | Infimed, Inc. | Biodegradable macromers for the controlled release of biologically active substances |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9061352B2 (en) | 2010-08-30 | 2015-06-23 | Pulmatrix, Inc. | Dry powder formulations and methods for treating pulmonary diseases |
US9233158B2 (en) | 2010-08-30 | 2016-01-12 | Pulmatrix, Inc. | Dry powder formulations and methods for treating pulmonary diseases |
Also Published As
Publication number | Publication date |
---|---|
JP4368198B2 (en) | 2009-11-18 |
EP1455755B1 (en) | 2013-04-17 |
US7182961B2 (en) | 2007-02-27 |
US20070104657A1 (en) | 2007-05-10 |
DK1455755T3 (en) | 2013-07-15 |
US20030129139A1 (en) | 2003-07-10 |
JP2005511628A (en) | 2005-04-28 |
EP1455755A4 (en) | 2007-05-09 |
ES2415654T3 (en) | 2013-07-26 |
EP1455755A2 (en) | 2004-09-15 |
AU2002352836A1 (en) | 2003-06-10 |
US7384649B2 (en) | 2008-06-10 |
PT1455755E (en) | 2013-06-18 |
AU2002352836B2 (en) | 2005-09-29 |
WO2003043585A2 (en) | 2003-05-30 |
CA2465675A1 (en) | 2003-05-30 |
CA2465675C (en) | 2008-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003043585A3 (en) | Improved particulate compositions for pulmonary delivery | |
WO2002043701A3 (en) | Method of making particles for use in a pharmaceutical composition | |
CA2447099A1 (en) | Delivery of compounds for the treatment of migraine through an inhalation route | |
PT2283817T (en) | Method of making particles for use in a pharmaceutical composition | |
EP2286797A3 (en) | Dry powder composition comprising co-jet milled particles for pulmonary inhalation | |
WO2002094244A3 (en) | Delivery of benzodiazepines through an inhalation route | |
WO2002009669A3 (en) | Apparatus and process to produce particles having a narrow size distribution and particles made thereby | |
WO2002094218A3 (en) | Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route | |
GB9827145D0 (en) | Improvements in or relating to powders | |
WO2002043695A3 (en) | Stable, aerosolizable suspensions of proteins (e.g. insulin, dnase) in ethanol | |
WO2005025506A3 (en) | Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation | |
CA2218116A1 (en) | Pulmonary delivery of aerosolized medicaments | |
WO2006002140A3 (en) | Compositions comprising amphotericin b | |
GB2374302A (en) | Power material for electrostatic application to a substrate and electrostatic application of the powder material to a substrate | |
WO2002040623A3 (en) | Fabric softening compositions and methods | |
ATE271383T1 (en) | POWDER FORMULATION FOR INHALATION | |
WO2005079755A3 (en) | Interleukin-13 antagonist powders, spray-dried particles, and methods | |
WO2003039459A3 (en) | Viral vector production methods and compositions | |
ATE407560T1 (en) | GRANULATED BREAD IMPROVEMENT FOR THE PRODUCTION OF PASTA | |
WO2002051389A3 (en) | Aerogel powder comprising therapeutic agents | |
WO2006015358A3 (en) | Aqueous suspension of nanoscale drug particles from supercritical fluid processing | |
WO2002072653A3 (en) | High build dispersions | |
JP2008231527A (en) | Powder for cold spray, and film formation method | |
TWI365111B (en) | Powder coating process | |
WO2002036158A8 (en) | Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002352836 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2465675 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003545266 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002789792 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002789792 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2002352836 Country of ref document: AU |